Frank X. Leonard
Chief Executive Officer · NovoCure Ltd
- 2024
- Jul 1, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Frank X. Leonard files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- William F. Doyle - $933K in NVCR purchases and sales in the last 12 months
- Mukund Paravasthu - $694K in NVCR purchases and sales in the last 12 months
- Uri Weinberg - $232K in NVCR purchases and sales in the last 12 months
- Christoph Brackmann - $85K in NVCR purchases and sales in the last 12 months
- Gabriel Leung - $46K in NVCR purchases and sales in the last 12 months
- Timothy J. Scannell - $46K in NVCR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Frank X. Leonard?
Frank X. Leonard is a corporate insider, tracked as Chief Executive Officer of NovoCure Ltd (NVCR). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Frank X. Leonard last file a Form 4?
The most recent primary Form 4 on record is dated 1 July 2026, one of 7 filings going back to 2024.
Has Frank X. Leonard been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($929K) across all tracked filings.
